Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.69 |
| ▸ | CA1 | P00915 | 3/20 | 0.69 |
| ▸ | CA2 | P00918 | 3/20 | 0.69 |
| ▸ | CA7 | P43166 | 3/20 | 0.69 |
| ▸ | CA9 | Q16790 | 3/20 | 0.69 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.69 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.69 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.69 |
| ▸ | GAA | P10253 | 2/20 | 0.65 |
| ▸ | MYC | P01106 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | IDO1 | P14902 | 1/20 | 0.55 |
| ▸ | TDO2 | P48775 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 2/20 | 0.54 |
| ▸ | RAB9A | P51151 | 2/20 | 0.54 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23045195 | 0.98 | CA12 (0.67) | CA12CA1CA2CA7CA9 | |
| SCHEMBL23231570 | 0.85 | CA12 (0.50) | CA12CA1CA2CA7CA9 | |
| SCHEMBL122473 | 0.84 | CA12 (0.69) | CA12CA1CA2CA7CA9 | |
| SCHEMBL27257996 | 0.84 | IDO1 (0.51) | CA12CA1CA2CA7CA9 | |
| SCHEMBL29640522 | 0.84 | CA12 (0.69) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1206018 | 0.83 | CYP46A1 (0.57) | CA12CA1CA2CA7CA9 | |
| SCHEMBL27341785 | 0.82 | NPC1 (0.49) | CA12CA1CA2CA7CA9 | |
| SCHEMBL23045197 | 0.82 | CA12 (0.67) | CA12CA1CA2CA7CA9 | |
| SCHEMBL28138691 | 0.82 | NPC1 (0.49) | CA12CA1CA2CA7CA9 | |
| SCHEMBL27460303 | 0.82 | NPC1 (0.49) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 497 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118240886-A | Method for synthesizing ethyl salicylate compound by biological enzyme catalysis | 济南大学 | 2024-06-25 | — | — | CN | claimed |
| US-10191398-B2 | Electrophotographic photoconductor, image forming apparatus, and process cartridge | RICOH COMPANY, LTD. (JP) | 2019-01-29 | — | — | US | claimed |
| CN-103694738-B | Isothiazole class dye composite and the method for dacron fabric short route basic dyeing thereof | SUZHOU UNIVERSITY (CN) | 2016-01-20 | — | — | CN | claimed |
| CN-105218329-A | Clean analogue intermediate of a kind of row and preparation method thereof | SHANGHAI INST TECHNOLOGY | 2016-01-06 | — | — | CN | claimed |
| CN-103694738-A | Isothiazole dye composition and method for applying isothiazole dye composition into short-process alkaline dyeing of polyester fabric | UNIV SOOCHOW | 2014-04-02 | — | — | CN | claimed |
| CN-103044963-A | Dye composition and method for short-process alkaline dyeing of polyester fiber fabric by using same | UNIV SOOCHOW | 2013-04-17 | — | — | CN | claimed |
| US-6458757-B1 | PROCESS FOR THE PRODUCTION OF PERFUMING COMPOSITIONS, PERFUMED PRODUCTS AND SUBSTANCES FOR PERFUMERY CHARACTERIZED IN THAT THEY COMPRISE, AS AN ACTIVE INGREDIENT WITH AN INFLUENCE ON THE SCENT, AN EFFECTIVE QUANTITY OF AN ALKYLSALICYLIC ACID | Chimie, Rhodia (FR) | 2002-10-01 | — | — | US | claimed |
| EP-0876325-B1 | METHOD FOR PREPARING SCENTING COMPOSITIONS AND SCENTED PRODUCTS, AND RESULTING PRODUCTS | RHODIA CHIMIE SA (FR) | 2002-01-09 | — | — | EP | claimed |
| US-20260138969-A1 | TRIAZOLE COMPOUND HAVING NOVEL RING STRUCTURE, METHOD FOR PREPARING SAME, AND USE THEREOF | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2026-05-21 | — | — | US | disclosed |
| CN-122037370-A | Conductive polypropylene composition, and preparation method and application thereof | 中国石油化工股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-12590062-B2 | PD-1/PD-L1 inhibitors | GILEAD SCIENCES, INC. (US) | 2026-03-31 | — | — | US | disclosed |
| US-20250377364-A1 | REAGENT, METHOD, AND DEVICE FOR DETECTING ALBUMIN | NEC CORPORATION (JP) | 2025-12-11 | — | — | US | disclosed |
| US-20250320318-A1 | OLEFIN POLYMERIZATION CATALYST COMPONENT, CATALYST SYSTEM, PREPOLYMERIZATION CATALYST COMPOSITION AND OLEFIN POLYMERIZATION METHOD | CHINA PETROLEUM & CHEM CORP (CN) | 2025-10-16 | — | — | US | disclosed |
| EP-3745105-B1 | TEMPERATURE DETECTION LABEL AND ARTICLE MANAGEMENT DEVICE USING SAME | HITACHI LTD (JP) | 2025-08-27 | — | — | EP | disclosed |
| EP-0348155-A1 | Quinoline derivatives as antagonists of leukotriene D4, compositions containing the same and processes for their preparation | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1989-12-27 | — | — | EP | disclosed |
| CN-87100978-A | Dihydrobenzofuran-and chroman-carboxamide derivatives, processes for their preparation and their use as neuroleptics | — | 1987-09-16 | — | — | CN | disclosed |
| CN-85109587-A | Have the new benzothiophene kind of antiallergic activity and the preparation method of benzofuran compounds | — | 1986-12-17 | — | — | CN | disclosed |
| EP-0083228-B1 | PHARMACEUTICALLY ACTIVE PHENYLCARBOXYLIC ACID DERIVATIVES | ICI AMERICAS INC. (US) | 1985-05-15 | — | — | EP | disclosed |
| US-4499299-A | Pharmaceutically active phenylcarboxylic acid derivatives | ICI AMERICAS INC. (US) | 1985-02-12 | — | — | US | disclosed |
| EP-0083228-A1 | Pharmaceutically active phenylcarboxylic acid derivatives | ICI AMERICAS INC. (US) | 1983-07-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260138969-A1 | TRIAZOLE COMPOUND HAVING NOVEL RING STRUCTURE, METHOD FOR PREPARING SAME, AND USE THEREOF | CASP1, CASP3, BAD | CA12 4257/4885CA1 278/4885CA2 2530/4885 |
| US-20250377364-A1 | REAGENT, METHOD, AND DEVICE FOR DETECTING ALBUMIN | ALB, TTR, MTTP | CA12 367/4885CA1 1488/4885CA2 3341/4885 |
| US-12590062-B2 | PD-1/PD-L1 inhibitors | CD274, PDCD1LG2, PDCD1 | CA12 2207/4885CA1 2733/4885CA2 3359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.